Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

link with dementia, hearing loss

Hearing loss and the link with dementia

If we address hearing loss, can we really decrease our risk of developing dementia? Mark Atkinson, Chief Executive Action of Hearing Loss investigates.

Intramembrane proteases in neurodegenerative diseases

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.
early alzheimers disease, virtual reality

Virtual reality can spot problems in early Alzheimer’s disease

The University of Cambridge found that virtual reality (VR) can identify early Alzheimer’s disease better than ‘gold standard’ cognitive tests currently in use.
with dementia

Up to 2 million will live with dementia by 2050

According to the Alzheimer Society 850,000 people in the UK have dementia but with 1 in 6 people over the age of 80 living with dementia, this is predicted to rise to over 2 million by 2050 as the population ages.
North America Analysis April 2019

North America Analysis – April 2019

Welcome to the April 2019 edition of North America Analysis. One of the highlights in this issue is the special focus we have on neurodegenerative diseases, which includes comment from Jeffrey Borenstein, of the Brain & Behavior Research Foundation (BBRF).
Alzheimer's disease research

Supporting vital Alzheimer’s disease research in the U.S and beyond

The work of the National Institute on Aging (NIA) is placed into focus here, with examples of how they are supporting vital Alzheimer’s disease research in the U.S and further afield.
dementia and alzheimer's

Defining dementia and Alzheimer’s in the 21st century

Paul Edwards, Director of Clinical Services at Dementia UK, explores what dementia actually means in the 21st century, including the all-important differences between dementia and Alzheimer’s.
living with Alzheimer's, Federal Affairs Alzheimer's association

Bold action by Congress delivers victory to millions living with Alzheimer’s

Rachel Conant, Senior Director, Federal Affairs, Alzheimer’s Association explains how bold action by the U.S. Congress delivers victory to the millions of people living with Alzheimer's.
Alzheimer's brain, Alzheimer's disease research

Scientists reveal largest ever map of human Alzheimer’s brain

On the 4th February 2019, a scientific breakthrough for the future of Alzheimer's brain reserach has been published - read on to explore the developments.
dementia research

Turning up the volume of the patient voice in dementia research

Dr James Pickett, Head of Research at Alzheimer’s Society presents the case for turning up the volume of the patient voice when it comes.
neurodegenerative disorders

Treatment and diagnosis of neurodegenerative disorders

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders
neurodegenerative diseases

Tackling neurodegenerative diseases including Alzheimer’s

The work of the EU Joint Programme – Neurodegenerative Disease Research (JPND) which aims to tackle the challenge of these diseases, in particular, Alzheimer’s, is discussed here
medical research

Dementia and Alzheimer’s disease: The priorities for medical research

Dr Carol Routledge, Director of Research at Alzheimer’s Research UK charts the priorities for medical research when it comes to dementia and Alzheimer’s disease
dementia sufferers

Halloween causes severe fear and confusion in dementia sufferers

Halloween is a fun time for many, dressing up, collecting as many sweets as possible and joining in on the community spirit. However, for dementia sufferers, Halloween can cause severe fear and confusion
loneliness

Theresa May launches UK’s first loneliness strategy

The prime minister has announced that all GPs in England will be able to refer patients suffering from loneliness to community activities by 2023.
challenge of dementia

A balanced approach to the global challenge of dementia

Dr Yves Joanette, Scientific Director at the CIHR Institute of Aging argues for a balanced approach when it comes to their collaboration-based approach to face the challenge of dementia
prevent Alzheimer's disease

Working to treat and prevent Alzheimer’s disease and related dementias

Dr Richard Hodes, Director of the National Institute on Aging within the U.S. National Institutes of Health, explores the importance of working together to treat and prevent Alzheimer’s disease and related dementias.
hearing loss

Addressing hearing loss could reduce the risk of Dementia

In recognition of World Alzheimer’s Day, hearing aid provider, Oticon, explains why successfully addressing hearing loss could reduce the risk of early on-set dementia
Alzheimer’s disease

Infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease

Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)
dementia research

Why more investment is needed to put people at the heart of dementia research

Colin Capper, Head of Research Development and Evaluation at Alzheimer’s Society, discusses why greater investment is needed in today’s dementia care research

Follow Open Access Government